[Therapeutic angiogenesis for coronary artery disease. Contemporary results and perspectives].
Therapeutic angiogenesis is referred to as development of new vasculature caused by various therapeutic measures such as: gene therapy, growth factors, percutaneous and transmyocardial laser revascularization. The scope of the current article is to provide review of performed clinical trials using therapeutic angiogenesis in patients with coronary artery disease.
Dudek
D
D
II Klinika Kardiologii Instytutu Kardiologii Instytut Kardiologii Collegium Medicum Uniwersytetu Jagiellońskiego, ul. Kopernika 17, 31-501 Kraków. mcdudek@cyf-kr.edu.pl
Heba
G
G
Rzeszutko
Ł
Ł
Dubiel
J S
JS
D043925:Angiogenesis Inducing Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003324:Coronary Artery Disease / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D016228:Endothelial Growth Factors / Q000627:therapeutic use; D015316:Genetic Therapy; D006133:Growth Substances / Q000627:therapeutic use*; D006801:Humans; D053685:Laser Therapy; D009204:Myocardial Revascularization / Q000379:methods*
D043925:Angiogenesis Inducing Agents; D016228:Endothelial Growth Factors; D006133:Growth Substances